Home › Essential Thrombocythemia › Utah
Essential Thrombocythemia clinical trials in Utah
5 studies for Essential Thrombocythemia are looking for participants at sites in Utah.
Cities in Utah
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07441694A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Huntsman Cancer Institute At University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07623200A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06661915A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Site US16, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07849231A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute At University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.